ProfileGDS4132 / 211632_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 50% 55% 26% 22% 45% 52% 43% 42% 35% 32% 33% 39% 28% 29% 24% 31% 32% 32% 31% 34% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101136.38150
GSM201543Muscle PCOS pioglitazone 121141.88955
GSM201544Muscle PCOS pioglitazone 16164.538226
GSM201545Muscle PCOS pioglitazone 20157.160622
GSM201829Muscle PCOS pioglitazone 231127.07945
GSM201830Muscle PCOS pioglitazon 251146.84152
GSM201831Muscle PCOS pioglitazone 271113.15443
GSM201832Muscle PCOS pioglitazone 31108.12342
GSM201833Muscle PCOS pioglitazone 4182.265635
GSM201834Muscle PCOS pioglitazone 8177.185332
GSM201835Muscle PCOS after pioglitazone 10267.449733
GSM201836Muscle PCOS after pioglitazone 12290.269739
GSM201837Muscle PCOS after pioglitazone 16255.867328
GSM201838Muscle PCOS after pioglitazone 20261.659529
GSM201839Muscle PCOS after pioglitazone 23249.262324
GSM201840Muscle PCOS after pioglitazone 25273.738331
GSM201841Muscle PCOS after pioglitazone 27265.367432
GSM201842Muscle PCOS after pioglitazone 3264.099232
GSM201843Muscle PCOS after pioglitazone 4275.924931
GSM201844Muscle PCOS after pioglitazone 8279.785634